查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594490

次世代定序儀市場：按技術、產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Next Generation Sequencing Market by Technology (Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Product Type (Consumables, Platforms, Services), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

次世代定序儀市場2023年估值為177.3億美元，預計2024年將達到213.8億美元，複合年成長率為23.61%，到2030年將達到782.1億美元。

次世代定序儀(NGS) 是一組遺傳技術，能夠對整個基因組或 DNA 或 RNA 的特定區域進行快速定序，為遺傳學和疾病檢測提供重要見解。 NGS 的需求在於其能夠高效、低成本地提供高通量測序資料，從而能夠在個人化醫療、遺傳研究甚至農業基因組學中得到應用。 NGS 主要用於研究環境、臨床診斷、生殖醫學、藥物基因組學和疾病管理。最終用途包括學術界、生技公司、製藥和醫療機構。關鍵的成長要素包括定序技術的進步、遺傳疾病盛行率的上升以及公共和私營部門對基因組學投資的增加。對個人化醫療以及腫瘤學和傳染病檢查新應用的需求迅速成長，代表著一個重大的商機。為了利用這些優勢，公司應該專注於開發具有成本效益、更快、更準確的定序技術，並擴展到正在投資基因組研究基礎設施的新興市場，例如亞太地區。然而，市場成長面臨著諸如高昂的初始設定成本、有關遺傳資料隱私的倫理問題以及監管障礙（尤其是在臨床應用方面）等挑戰。資料解釋的局限性和技術純熟勞工的缺乏也阻礙了快速採用。創新應著重於整合人工智慧和機器學習進行資料分析、開發更直覺的生物資訊學工具以及提高序列組裝準確性。市場高度活躍，反映出疫情後技術的快速進步和公共衛生優先事項的變化，並且需要敏捷性和持續的研發投資才能保持競爭力。從策略上講，公司應考慮與學術研究機構合作並擴大其服務範圍，包括全面的基因組資料解釋服務，以解決 NGS效用的關鍵瓶頸。

主要市場統計
基準年[2023] 177.3億美元
預測年份 [2024] 213.8億美元
預測年份 [2030] 782.1億美元
複合年成長率（%） 23.61%

市場動態：揭示快速發展的次世代定序儀市場的關鍵市場洞察

供需的動態交互作用正在改變次世代定序儀市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • NGS 技術在臨床診斷中的廣泛採用。
    • NGS 應用擴大，腫瘤學研究經費激增
    • 農業領域擴大採用分析植物遺傳潛力的方法
  • 市場限制因素
    • 缺乏計算資源和人員來分析和解釋臨床資料
  • 市場機會
    • 繼續專注於開發新技術和基於 NGS 的產品商業化
    • 政府和私營部門增加對大規模測序技術的支持
  • 市場挑戰
    • 關於次世代定序儀資料保護的道德和隱私問題

波特五力：駕馭次世代定序儀市場的策略工具

波特的五力架構是了解次世代定序儀市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對次世代定序儀市場的影響

外部宏觀環境因素在塑造次世代定序儀市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解次世代定序儀市場的競爭狀況

次世代定序儀市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣次世代定序儀供應商市場績效評估

FPNV定位矩陣是評估次世代定序儀市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了次世代定序儀市場的成功之路

次世代定序儀市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於快速結果和快速處理，NGS 技術在臨床診斷中廣泛採用
      • 擴大 NGS 的應用並迅速增加腫瘤學研究的資金
      • 農業領域擴大採用分析植物遺傳潛力的方法
    • 抑制因素
      • 缺乏計算資源和人員來分析和解釋臨床資料
    • 機會
      • 繼續專注於開發新技術和基於 NGS 的產品商業化
      • 政府和私營部門增加對大規模定序技術的支持
    • 任務
      • 關於次世代定序儀資料保護的道德和隱私問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章次世代定序儀市場：依技術分類

  • 標靶定序和定序
  • 全EXOME定序
  • 全基因組序列分析

第7章次世代定序儀市場：依產品類型

  • 消耗品
  • 平台
  • 服務

第 8 章次世代定序儀市場：按應用分類

  • 農業
  • 動物科學和獸醫研究
  • 診斷
  • 藥物發現

第 9 章次世代定序儀市場：按最終用戶分類

  • 學術研究所
  • 臨床實驗室
  • 合約調查機構
  • 醫院/診所
  • 製藥和生物技術公司

第10章 美洲次世代定序儀市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區次世代定序儀市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲次世代定序儀市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • QIAGEN 完成對 Verogen 的收購，透過 NGS 技術加強人類 ID/法醫學領先地位。
    • QIAGEN 和 Helix 開始建立獨家夥伴關係，以推進遺傳疾病的次世代定序伴同性診斷。
    • 安捷倫宣布收​​購 Avida Biomed，該公司是癌症研究高性能 NGS靶向序列捕獲的開發商。
    • Integrated DNA Technologies 從 Invitae Corporation 收購了 ArcherDX次世代定序儀研究檢測。
    • 華大智造旗下Complete Genomics在ASHG年會上發表了次世代定序平台。
    • 澳洲華大基因 (BGI Australia) 獲得 NATA 臨床全EXOME序認證。
    • ASM 宣布 CDC 資助的基因組監測培訓計劃。
    • NGS 生物安全測試和生物製藥表徵領域的領先專家在美國主要市場推出了新功能。
    • Illumina 發布下一代 DNA 定序儀。
    • Thermo Fisher Scientific 推出了次世代定序儀器。
    • Illumina 和 Trivitron 聯手加速印度患者的疾病檢測和診斷。
  • 戰略分析和建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • ATDBio Ltd.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • BIO3 SCIENTIFIC SDN BHD
  • bioMerieux SA
  • BioVendor-Laboratorni medicina as
  • Cambridge Bioscience Limited
  • CD Genomics
  • CeGaT GmbH
  • Charles River Laboratories, Inc.
  • DNAnexus, Inc.
  • DNASTAR, Inc.
  • ELEMENT BIOSCIENCES
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Fraunhofer-Gesellschaft
  • GENEWIZ
  • Genomatix
  • GenPath
  • GenScript Biotech Corporation
  • GRAIL, LLC
  • Hamilton Company
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invivoscribe, Inc.
  • iRepertoire, Inc.
  • LabMal
  • Macrogen, Inc.
  • Medigene Sdn Bhd.
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Neoscience
  • Norgen Biotek Corp.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • PathoQuest
  • PCR Biosystems Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • PT Pandu Biosains
  • Qiagen NV
  • Resolution Bioscience, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4312A385A68A

The Next Generation Sequencing Market was valued at USD 17.73 billion in 2023, expected to reach USD 21.38 billion in 2024, and is projected to grow at a CAGR of 23.61%, to USD 78.21 billion by 2030.

Next Generation Sequencing (NGS) represents a suite of genetic technologies that allow rapid sequencing of entire genomes or specific areas of DNA or RNA, offering significant insights into genetics and disease detection. Its necessity is anchored in its ability to provide high-throughput sequencing data efficiently and at decreasing costs, enabling advances in personalized medicine, genetic research, and even applications in agrigenomics. NGS is primarily used in research settings, clinical diagnostics, reproductive health, pharmacogenomics, and disease management. The end-use spectrum spans academia, biotechnology firms, pharmaceuticals, and healthcare facilities. Key growth factors include advancements in sequencing technology, rising prevalence of genetic disorders, and increasing investments in genomics by both public and private sectors. The surge in demand for personalized medicine and new applications in oncology and infectious disease testing are significant opportunities. To capitalize on these, businesses should focus on developing cost-effective, faster, and more accurate sequencing technologies and expand into emerging markets that are investing in genomic research infrastructures, like APAC. Nonetheless, market growth faces challenges such as high initial setup costs, ethical concerns regarding genetic data privacy, and regulatory hurdles, especially concerning clinical applications. Limitations in data interpretation and lack of skilled workforce also impede rapid adoption. Innovations should focus on AI and machine learning integration for data analysis, development of more intuitive bioinformatics tools, and improvements in sequence assembly accuracy. The market is highly dynamic, reflecting rapid technological advances and shifting public health priorities post-pandemic, necessitating agility and continued investment in R&D to remain competitive. Strategically, firms should consider partnerships with academic research institutions and expansion of service offerings to include comprehensive genomic data interpretation services, addressing a key bottleneck in NGS utility.

KEY MARKET STATISTICS
Base Year [2023] USD 17.73 billion
Estimated Year [2024] USD 21.38 billion
Forecast Year [2030] USD 78.21 billion
CAGR (%) 23.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Sequencing Market

The Next Generation Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processin
    • Increased application of NGS and exponential availability of funds for oncology research
    • Emerging adoption in the agriculture sector to analyze the genetic potential of plants
  • Market Restraints
    • Lack of the computational resources and staffing to analyze and interpret clinical data
  • Market Opportunities
    • Continuous focus on new technology development and commercialization of NGS based products
    • Increased support from government and private sector for large scale sequencing technology
  • Market Challenges
    • Ethical and privacy concerns related to next generation sequencing data protection

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Sequencing Market

A detailed market share analysis in the Next Generation Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next Generation Sequencing Market

A strategic analysis of the Next Generation Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., ATDBio Ltd., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BIO3 SCIENTIFIC SDN BHD, bioMerieux S.A., BioVendor-Laboratorni medicina a.s, Cambridge Bioscience Limited, CD Genomics, CeGaT GmbH, Charles River Laboratories, Inc., DNAnexus, Inc., DNASTAR, Inc., ELEMENT BIOSCIENCES, Enzo Life Sciences, Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fraunhofer-Gesellschaft, GENEWIZ, Genomatix, GenPath, GenScript Biotech Corporation, GRAIL, LLC, Hamilton Company, Illumina, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., iRepertoire, Inc., LabMal, Macrogen, Inc., Medigene Sdn Bhd., Merck KGaA, NanoString Technologies, Inc., Neoscience, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PathoQuest, PCR Biosystems Ltd., Perkin Elmer, Inc., Promega Corporation, PT Pandu Biosains, Qiagen N.V., Resolution Bioscience, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Product Type, market is studied across Consumables, Platforms, and Services.
  • Based on Application, market is studied across Agriculture, Animal science & Veterinary Research, Diagnostics, and Drug Discovery.
  • Based on End User, market is studied across Academic & Research Institutes, Clinical Laboratories, Contract Research Organization, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processin
      • 5.1.1.2. Increased application of NGS and exponential availability of funds for oncology research
      • 5.1.1.3. Emerging adoption in the agriculture sector to analyze the genetic potential of plants
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of the computational resources and staffing to analyze and interpret clinical data
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous focus on new technology development and commercialization of NGS based products
      • 5.1.3.2. Increased support from government and private sector for large scale sequencing technology
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and privacy concerns related to next generation sequencing data protection
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next Generation Sequencing Market, by Technology

  • 6.1. Introduction
  • 6.2. Targeted Sequencing & Re-Sequencing
  • 6.3. Whole Exome Sequencing
  • 6.4. Whole Genome Sequencing

7. Next Generation Sequencing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Platforms
  • 7.4. Services

8. Next Generation Sequencing Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture
  • 8.3. Animal science & Veterinary Research
  • 8.4. Diagnostics
  • 8.5. Drug Discovery

9. Next Generation Sequencing Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Laboratories
  • 9.4. Contract Research Organization
  • 9.5. Hospitals & Clinics
  • 9.6. Pharmaceutical & Biotechnology Companies

10. Americas Next Generation Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Next Generation Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Next Generation Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies.
    • 13.3.2. QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases.
    • 13.3.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research.
    • 13.3.4. Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation.
    • 13.3.5. Complete Genomics, part of MGI, Announces Next-Generation Sequencing Platforms at ASHG Annual Meeting.
    • 13.3.6. BGI Australia receives NATA certification for clinical whole exome sequencing.
    • 13.3.7. ASM Announces CDC-Funded Genomic Surveillance Training Program.
    • 13.3.8. The Leading Experts in NGS Biosafety Testing and Characterization of Biopharmaceuticals Launch New Capabilities in the Critical U.S. Market.
    • 13.3.9. Illumina launches next-generation DNA sequencers.
    • 13.3.10. Thermo Fisher Scientific Launches CE-IVD Marked Next-Generation Sequencing Instrument for Use in Clinical Labs.
    • 13.3.11. Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. ATDBio Ltd.
  • 4. BGI Genomics Co., Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BIO3 SCIENTIFIC SDN BHD
  • 7. bioMerieux S.A.
  • 8. BioVendor-Laboratorni medicina a.s
  • 9. Cambridge Bioscience Limited
  • 10. CD Genomics
  • 11. CeGaT GmbH
  • 12. Charles River Laboratories, Inc.
  • 13. DNAnexus, Inc.
  • 14. DNASTAR, Inc.
  • 15. ELEMENT BIOSCIENCES
  • 16. Enzo Life Sciences, Inc.
  • 17. Eppendorf SE
  • 18. Eurofins Scientific SE
  • 19. F. Hoffmann-La Roche Ltd.
  • 20. Fraunhofer-Gesellschaft
  • 21. GENEWIZ
  • 22. Genomatix
  • 23. GenPath
  • 24. GenScript Biotech Corporation
  • 25. GRAIL, LLC
  • 26. Hamilton Company
  • 27. Illumina, Inc.
  • 28. Integrated DNA Technologies, Inc.
  • 29. Invivoscribe, Inc.
  • 30. iRepertoire, Inc.
  • 31. LabMal
  • 32. Macrogen, Inc.
  • 33. Medigene Sdn Bhd.
  • 34. Merck KGaA
  • 35. NanoString Technologies, Inc.
  • 36. Neoscience
  • 37. Norgen Biotek Corp.
  • 38. Oxford Nanopore Technologies PLC
  • 39. Pacific Biosciences of California, Inc.
  • 40. PathoQuest
  • 41. PCR Biosystems Ltd.
  • 42. Perkin Elmer, Inc.
  • 43. Promega Corporation
  • 44. PT Pandu Biosains
  • 45. Qiagen N.V.
  • 46. Resolution Bioscience, Inc.
  • 47. Takara Bio Inc.
  • 48. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NEXT GENERATION SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT GENERATION SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT GENERATION SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT GENERATION SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023